Vendor Oversight Under ICH E6(R3): Why Compliance Expectations Are Higher Than Ever
May 21, 2026
Vendor oversight has always been part of clinical trial compliance, but ICH E6(R3) has significantly raised expectations for sponsors and technology vendors alike.
The updated guideline makes one thing very clear: sponsors remain fully responsible for trial quality, patient safety, and data integrity — even when activities are outsourced to external vendors. This includes ensuring that computerized systems used in clinical trials are validated, properly controlled, and fit for their intended use.
Today, vendor qualification is no longer just an onboarding checklist. Regulators increasingly expect continuous oversight throughout the entire vendor relationship lifecycle.
At Flex Databases, compliance readiness is built into the platform and our operational approach. We support sponsors with structured validation documentation, transparent audit trails, role-based access controls, and detailed system lifecycle documentation to simplify qualification and ongoing oversight activities.
Our goal is simple: help clients stay inspection-ready while reducing the operational burden of compliance management. Under ICH E6(R3), vendor oversight is an ongoing governance responsibility and we are fully prepared to support that framework.
If you are reviewing your compliance strategy under the new guidelines, Flex Databases can help make the process significantly easier.
